KEVIN FERGUSON: Open Payments
NPI 1164530036 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,941 in 153 payments from 18 companies in 2025. Trend: 2023 $17,766 · 2024 $3,469 · 2025 $3,941
Food & beverage: $3,941
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $717 |
| Neurocrine BioSciences, Inc. | 22 | $627 |
| Alkermes, Inc. | 16 | $451 |
| Vanda Pharmaceuticals Inc. | 12 | $403 |
| Otsuka America Pharmaceutical, Inc. | 21 | $337 |
| Corium, LLC | 10 | $230 |
| Supernus Pharmaceuticals, Inc. | 8 | $190 |
| ABBVIE INC. | 7 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $135 |
| Teva Pharmaceuticals USA, Inc. | 5 | $122 |
Products named: INGREZZA, FANAPT, LYBALVI, REXULTI, Sunosi, Auvelity, Azstarys, Qelbree.
Industry payments across TN — which companies pay providers there.
